Eterna Therapeutics
ERNA
6 hedge funds and large institutions have $3.01M invested in Eterna Therapeutics in 2019 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
112% more capital invested
Capital invested by funds: $1.42M → $3.01M (+$1.59M)
0% more funds holding
Funds holding: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$47.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NSIM
1
North Star Investment Management
Chicago,
Illinois
| $1.26M | +$47.9K | +1 | +5% |
|
|
BA
2
Bard Associates
Chicago,
Illinois
| $1.16M | – | – | – |
|
3
Renaissance Technologies
New York
| $201K | – | – | – |
|
4
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $121K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $85K | – | – | – |
|
|
CA
6
Callahan Advisors
Houston,
Texas
| $76K | – | – | – |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $65K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $27K | – | – | – |
|
9
BlackRock
New York
| $12K | – | – | – |
|
|
LTFS
10
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
11
Bank of America
Charlotte,
North Carolina
| – | -$2K | – | – |
|
ERNA Hedge Fund Activity: Q1 2019 in Review
6 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q1 2019, worth a combined $3.01M — up 112% from $1.42M a quarter earlier.
Fund positioning in ERNA was balanced in Q1 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was North Star Investment Management, adding an estimated $47.9K. The largest seller was Bank of America, cutting an estimated $2K.
- 6 institutional investors held Eterna Therapeutics (ERNA) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $3.01M of Eterna Therapeutics stock for Q1 2019, up 112% quarter-over-quarter.
- 0 funds opened new Eterna Therapeutics positions in Q1 2019 and 0 closed out.
- The largest Eterna Therapeutics buyer in Q1 2019 was North Star Investment Management, an estimated $47.9K added.
- The largest Eterna Therapeutics seller in Q1 2019 was Bank of America, an estimated $2K sold.
Based on aggregated 13F filings for Q1 2019.